QNRX
Quoin Pharmaceuticals Ltd DRC
NASDAQ: QNRX · HEALTHCARE · BIOTECHNOLOGY
$6.21
-4.17% today
Updated 2026-05-01
Market cap
$9.83M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-14.80
Dividend yield
—
52W range
$5 – $24
Volume
0.1M
WallStSmart proprietary scores
29
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C5.0
Quality
C+3.0
Profitability
D5.0
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →205 stocks currently score above 75
Price targets
Analyst target
$29.67
+377.78%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
1 Strong Buy1 Buy0 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-5.08M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-9.38M | $-8.69M | $-8.96M | $-15.80B | $-15.79B |
| EPS | — | — | — | — | $-14.80 |
| Free cash flow | $-8.73M | $-7.86M | $-7.86M | $-13.54B | $-5.08M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
Quoin Pharmaceuticals Ltd DRC trades at $6.21. Our Smart Value Score of 29/100 indicates the stock is weak.
Frequently asked questions
What is Quoin Pharmaceuticals Ltd DRC's stock price?
Quoin Pharmaceuticals Ltd DRC (QNRX) trades at $6.21.
Is Quoin Pharmaceuticals Ltd DRC overvalued?
Smart Value Score 29/100 (Grade F, Strong Sell).
What is the price target of Quoin Pharmaceuticals Ltd DRC (QNRX)?
The analyst target price is $29.67, representing +377.8% upside from the current price of $6.21.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-141.60%
Beta1.82
50D MA$7.43
200D MA$9.83
Shares out0.00B
Float0.05B
Short ratio—
Avg volume0.1M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—